Understanding Biotherapeutic Peptides and GLP-1 Receptor Agonists

Analysis and Characterization

Evaluate amino acids, resin, and other starting materials before downstream processing begins.

Purification

Support process purification and confirm analytical performance through key workflow transitions.

Impurity and Variant Characterization

Assess the peptide drug substance for identity, purity, & critical quality attributes.

Aggregate analysis and Particulate analysis

Assess your GLP-1 product for aggregation, size and oligomeric state

Quality Control in Manufacturing

Evaluate the finished drug product using methods fit for release and QC workflows.